Pinnacle Treatment Centers Expands Options for Opioid Recovery
Pinnacle Treatment Centers, a renowned leader in delivering evidence-based care for individuals dealing with Substance Use Disorder, is excited to announce innovative new medications now available at their New Jersey facilities. The addition of Sublocade, Brixadi, and Vivitrol marks a significant enhancement in treatment options for individuals grappling with Opioid Use Disorder.
Understanding the New Medications
Sublocade is an impressive once-monthly injection of buprenorphine. It's specifically crafted to help individuals manage cravings and withdrawal symptoms that arise when abstaining from opioid consumption. This remarkable medication plays a vital role in stabilizing patients by effectively addressing Opioid Use Disorder symptoms, maintaining consistent medication levels through a hassle-free monthly injection. It particularly benefits those already on oral buprenorphine treatments, such as Suboxone.
Flexible Treatment with Brixadi
Brixadi provides unparalleled flexibility with both weekly and monthly injection options. This injectable extended-release buprenorphine medication aims to alleviate cravings and withdrawal symptoms, similar to Sublocade, but allows healthcare providers to personalize the treatment for each individual's recovery journey. Its adaptable dosing makes it an appealing choice for various recovery stages, ensuring that patients receive the support necessary for their paths to sobriety.
Preventing Relapse with Vivitrol
The monthly injection of Vivitrol acts by blocking opioid receptors. It effectively diminishes the cravings associated with opioids and reduces the chances of relapse by eliminating the physical and emotional sensations tied to opioid use. Approved for both opioid and alcohol use disorders, this medication plays a crucial role in supporting long-term recovery by preventing the euphoric effects of opioid substances. However, a thorough withdrawal management process is necessary before a patient begins treatment with Vivitrol to avoid withdrawal symptoms.
Commitment to Comprehensive Care
Dr. Daniel Brown, the Chief Medical Officer at Pinnacle Treatment Centers, emphasized the commitment to providing lasting treatment solutions. He expressed, "At Pinnacle Treatment Centers, we recognize the importance of offering effective care for individuals battling Opioid Use Disorder. With medications like Sublocade, Brixadi, and Vivitrol, we are enabling broader access to scientifically-backed treatment that aids in sustained recovery. Reducing cravings fosters a steady commitment to long-term sobriety and allows patients to reclaim their lives with confidence and support. We prioritize ensuring all individuals receive the comprehensive care they require throughout their recovery journeys."
Supporting Patients and Community Partners
All three new medications will be available at every Pinnacle location in the state, providing consistency in care along with simplified treatment plans. This availability represents a significant step toward aiding patients in their recovery efforts.
Community Collaboration
Pinnacle Treatment Centers invites community partners to extend support to individuals seeking recovery solutions. If there are patients who could greatly benefit from these new treatment options, partners are encouraged to reach out to the 24/7 Access Center at 85-PINNACLE (857-466-2253) to refer patients or seek additional information. Pinnacle's commitment to fostering recovery aligns with its mission to connect patients with the resources they need.
About Pinnacle Treatment Centers
Pinnacle Treatment Centers has earned a reputation as a leading provider of comprehensive substance abuse treatment services across various states. Established with a firm commitment to accessible and cost-effective care, Pinnacle offers a diverse array of addiction treatment services. These include medically supervised withdrawal management, inpatient and outpatient care, sober living programs, and Medications for Opioid Use Disorder. By incorporating established practices and individualized care plans, Pinnacle addresses the unique needs of every person it serves. Their overarching goal is to empower patients in achieving enduring recovery while enhancing their overall quality of life through compassionate support and professional guidance.
Frequently Asked Questions
What medications have been introduced by Pinnacle Treatment Centers?
Pinnacle Treatment Centers has introduced three new medications: Sublocade, Brixadi, and Vivitrol, for individuals facing opioid use challenges.
How does Sublocade assist patients with Opioid Use Disorder?
Sublocade is a monthly injectable medication designed to ease cravings and withdrawal symptoms, providing stable medication levels for those recovering from opioid dependence.
What makes Brixadi different from other opioid treatments?
Brixadi offers both weekly and monthly dosing options, allowing clinicians to tailor treatment based on the specific needs and stages of recovery of each patient.
How does Vivitrol help in preventing relapse?
Vivitrol blocks opioid receptors, thus preventing the euphoric effects associated with opioid use and helping individuals maintain their recovery journey.
What support does Pinnacle provide to community partners?
Pinnacle invites community partners to collaborate in supporting patients, providing resources, and referring individuals who could benefit from the new treatment options.
